<?xml version="1.0" encoding="UTF-8"?>
<p id="p0165">As mentioned above, LF alone or in combination with OSCN
 <sup>âˆ’</sup> is already being tested in a phase 1 clinical trial (RCT02598999) on healthy volunteers and patients affected by cystic fibrosis (
 <xref rid="bib2" ref-type="bibr">Alaxia, 2020</xref>; 
 <xref rid="bib14" ref-type="bibr">Cegolon, 2020</xref>).
</p>
